Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota and intestinal contents represent a complex biological system comprising trillions of microorganisms—including bacteria, fungi, and viruses—and the metabolic environment of the gastrointestinal tract. This ecosystem is fundamental to human physiology, contributing to the fermentation of non-digestible carbohydrates, the synthesis of essential vitamins such as K and B12, and the maturation of the mucosal immune system (StatPearls, 2023). Dysbiosis, characterized by a loss of microbial diversity or an overgrowth of opportunistic pathogens, is strongly associated with diseases such as inflammatory bowel disease, metabolic syndrome, and Clostridioides difficile infections (Nature Reviews Microbiology, 2020). Therapeutic strategies targeting this system include the use of probiotics, prebiotics, and fecal microbiota transplantation (FMT) to restore ecological balance and metabolic function (Mayo Clinic, 2023). Additionally, the gut microbiota significantly influences the pharmacokinetics of various drugs through microbial biotransformation, which can alter both therapeutic efficacy and systemic toxicity (NIH, 2015). Understanding the interplay between these microbes and their host is crucial for developing precision medicine approaches in gastroenterology and metabolic health.
Modulation of microbial composition and diversity, competitive inhibition of pathogenic species, and production of bioactive metabolites such as short-chain fatty acids (Nature Reviews Microbiology, 2020).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota and intestinal contents.